Truvestments Capital LLC Purchases New Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Truvestments Capital LLC purchased a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the third quarter, HoldingsChannel.com reports. The firm purchased 6,989 shares of the pharmacy operator’s stock, valued at approximately $63,000.

A number of other hedge funds also recently bought and sold shares of WBA. Charles Schwab Investment Management Inc. increased its holdings in Walgreens Boots Alliance by 43.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after purchasing an additional 3,329,857 shares during the period. Thompson Siegel & Walmsley LLC increased its holdings in Walgreens Boots Alliance by 98.8% during the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after purchasing an additional 2,992,648 shares during the period. Newport Trust Company LLC purchased a new position in Walgreens Boots Alliance during the 2nd quarter valued at about $31,028,000. Swedbank AB purchased a new position in Walgreens Boots Alliance during the 1st quarter valued at about $16,365,000. Finally, Philip James Wealth Mangement LLC bought a new stake in Walgreens Boots Alliance during the 3rd quarter valued at approximately $5,252,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on WBA shares. Truist Financial cut their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Jefferies Financial Group cut their price objective on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, October 23rd. Barclays lifted their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 16th. UBS Group lifted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Finally, TD Cowen cut their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, October 22nd. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus target price of $12.88.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA opened at $9.06 on Thursday. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $27.05. The firm has a market cap of $7.83 billion, a P/E ratio of -0.91, a PEG ratio of 1.19 and a beta of 0.69. The company has a 50 day moving average of $9.13 and a 200 day moving average of $11.37. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company had revenue of $37.50 billion during the quarter, compared to analyst estimates of $35.75 billion. During the same period in the previous year, the business earned $0.67 EPS. The firm’s revenue for the quarter was up 5.9% on a year-over-year basis. As a group, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 11.04%. Walgreens Boots Alliance’s payout ratio is currently -9.99%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.